Search results
Understand the peri-operative management, staging, and surgical oncology principles for cutaneous MCT in dogs and cats, and the indications for adjunctive radiation therapy or chemotherapy in conjunction with surgery. Understand treatment options for non-resectable MCTs.
5 kwi 2024 · As treatment recommendations and prognostic factors for MCTs continually change, this article aims to demystify the clinical approach to MCTs by reviewing indications for use of the MCT prognostic panel, the clinical relevance of regional lymph node metastasis, and various local and systemic therapies.
1 mar 2011 · The treatment of both nonerosive and erosive IMPA involves immunosuppressive, immunomodulating, and disease-modifying drugs. In dogs with nonerosive IMPA, the prognosis and response to treatment vary according to cause but is often guarded to good, with many patients responding to single agent or combination drug therapy.
Our team can deploy a variety of tests to determine the best treatment for your pet and they have access to state-of-the-art equipment to verify treatment progress. BluePearl has a network of board-certified radiologists who can also provide your family veterinarian with imaging interpretations.
Blood smear in a dog with immune-mediated haemolytic anaemia. Note the anisocytosis (variable size of red blood cells) and polychromasia (presence of polychromatophils: immature red blood cells that are larger and more basophilic; green arrows).
Treatment for an infectious (bacterial) polyarthritis involves antibiotic therapy. Treatment for immune-mediated polyarthritis involves the use of a single drug or multiple drugs to “turn off” or suppress the immune system.
Immune-mediated polyarthritis (IMPA) is an important condition to recognize in dogs. Treatment of IMPA is significantly different than treatment of many other conditions that may present with similar clinical signs, and protocols may vary between patients. Therefore, making an accurate diagnosis is critical.
